CONFIDENTIAL PORTIONS HAVE BEEN OMITTED BASED UPON A REQUEST FOR CONFIDENTIAL TREATMENT PURSUANT TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934 AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION. DISTRIBUTION AGREEMENT (JAPAN)Distribution Agreement • August 13th, 2003 • Micro Therapeutics Inc • Surgical & medical instruments & apparatus • Minnesota
THIS AGREEMENT is made as of June 1, 2003 (“Effective Date”), by and been Micro Therapeutics, inc., a Delaware corporation with its principal place of business at 2 Goodyear, Irvine California (“MTI”) and ev3 K.K., a Japanese corporation with its principal place of business at 2-28-I, Nihonbashi-Hamacho, Chuo-ku, Tokyo (“ev3”).
CONFIDENTIAL PORTIONS HAVE BEEN OMITTED BASED UPON A REQUEST FOR CONFIDENTIAL TREATMENT PURSUANT TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934 AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION. DISTRIBUTION SUPPORT SERVICES AGREEMENTDistribution Support Services Agreement • August 13th, 2003 • Micro Therapeutics Inc • Surgical & medical instruments & apparatus • California
THIS AGREEMENT is made as of June 2, 2003 (“Effective Date”), by and between Micro Therapeutics, Inc., a Delaware corporation with its principal place of business at 2 Goodyear, Irvine, California (“MTI”) and ev3 Inc., a Delaware corporation with its principal place of business at 4600 Nathan Lane North, Plymouth, Minnesota 55442-2920 (“ ev3”).
CONFIDENTIAL PORTIONS HAVE BEEN OMITTED BASED UPON A REQUEST FOR CONFIDENTIAL TREATMENT PURSUANT TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934 AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION. DISTRIBUTION AGREEMENT (CANADA)Distribution Agreement (Canada) • August 13th, 2003 • Micro Therapeutics Inc • Surgical & medical instruments & apparatus • Minnesota
THIS AGREEMENT is made as of June 1, 2003 (“Effective Date”), by and between Micro Therapeutics, Inc., a Delaware corporation with its principal place of business at 2 Goodyear, Irvine California (“MTI”) and ev3 Canada, Inc., a Canadian corporation with its principal place of business at 4600 Nathan Lane North, Plymouth MN 55442-2890 U.S.A. (“ev3”).
CONFIDENTIAL PORTIONS HAVE BEEN OMITTED BASED UPON A REQUEST FOR CONFIDENTIAL TREATMENT PURSUANT TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934 AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION. AMENDED AND RESTATED SALES REPRESENTATIVE AGREEMENTSales Representative Agreement • August 13th, 2003 • Micro Therapeutics Inc • Surgical & medical instruments & apparatus • Minnesota
This Agreement amends and restates in its entirety that certain Sales Representative Agreement, dated as of November 16, 2001, as amended on April 18, 2002 and May 20, 2002 (the “Original Agreement”).
FIRST AMENDMENT TO LEASETo Lease • August 13th, 2003 • Micro Therapeutics Inc • Surgical & medical instruments & apparatus
This First Amendment to the Lease (the “Amendment”) dated May 28, 2003 is made by and between EJM DEVELOPMENT CO., a California limited partnership (“Landlord”), and MICRO THERAPEUTICS, INC., a California corporation, (“Tenant”), who have entered into this First Amendment with reference to the following facts:
